• AAPL 169.02
  • TSLA 162.13
  • AMZN 176.59
  • MSFT 409.06
  • INTC 34.5
  • EURUSD 1.073
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. BBLG.NASDAQ

Bone Biologics Corp (BBLG NASDAQ) stock market data APIs

$1.58 0.05(3.3%) as of April 24, 2024

Bone Biologics Corp Financial Data Overview

1.5251
1.58
-
1.608
1.46
1.46-72
1 354 K
879 K
0
-3.38
0.578
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'BBLG',
Type: 'Common Stock',
Name: 'Bone Biologics Corp',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
ISIN: NULL,
CUSIP: NULL,
CIK: '1419554',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2016-03-31',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Medical Devices',
HomeCategory: NULL,
IsDelisted: false,
}

Bone Biologics Corp Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -824 964
  • Earnings Per Share -34.01
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Bone Biologics Corp Earnings via APIs

  • Latest Release 2024-02-21
  • EPS/Forecast -5.6

Get Bone Biologics Corp End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Bone Biologics Corp latest news via APIs

Bone Biologics Prices $5.0 Million Underwritten Public Offering

BURLINGTON, Mass., June 15, 2023--(BUSINESS WIRE)--Bone Biologics Corporation (NASDAQ: BBLG) ("Bone Biologics" or the "Company"), a developer of orthobiologic products for spine fusion markets, today ...

BBLG: BBLG Advances Crucial Technology and Solidifies Funding

By Brad Sorensen, CFA NASDAQ:BBLG READ THE FULL BBLG RESEARCH REPORT Bone Biologics (NASDAQ:BBLG) recently announced that it has received approval to begin pilot clinical trials with NB1 in spinal ...
Do you have any questions?
support@eodhistoricaldata.com